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Abstract
The purpose of this study was to assess vitamin B6 intake and status in Korean patients with newly diagnosed type 2 diabetes. Sixty-four patients
with newly diagnosed type 2 diabetes and 8-11% glycated hemoglobin (A1C), along with 28 age-matched non-diabetic subjects, participated. Dietary
vitamin B6 intake was estimated by the 24 hour recall method and plasma pyridoxal 5'-phosphate (PLP) was measured. There was a significant
difference in daily total calorie intake between the diabetic and non-diabetic groups (1,917 ± 376 vs 2,093 ± 311 kcal). There were no differences
in intake of total vitamin B6 (2.51 ± 0.91 vs 2.53 ± 0.81 mg/d) or vitamin B6/1,000 kcal (1.31 ± 0.42 vs 1.20 ± 0.32 mg) between the diabetic and
non-diabetic groups, andI intakes of total vitamin B6 were above the Korean RDA in both groups (180.0 ± 57.9 vs 179.0 ± 65.4). There was a higher
percentage of diabetic subjects whose plasma PLP concentration was < 30 nmol/L compared to non-diabetic group. Plasma PLP levels tended to 
be lower in the diabetic subjects than in the non-diabetic subjects, although the difference was not statistically significant due to a large standard
deviation (80.0 ± 61.2 nmol/L vs 68.2 ± 38.5 nmol/L). Nevertheless, plasma PLP levels should be monitored in pre-diabetic patients with diabetic
risk factors as well as in newly diagnosed diabetic patients for long-term management of diabetes, even though this factor is not a major risk
factor that contributes to the development of degenerative complications in certain patients.
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Introduction5)
In developed countries, classical vitamin-deficiency syndromes 
such as scurvy, beriberi, and pellagra are now uncommon, but 
specific population subgrozups remain at risk for modest vitamin 
insufficiencies. This is notably the case in diabetes patients who 
frequently display inadequate vitamin status, including many 
from the B group. Diabetes mellitus is a metabolic disorder 
characterized by hyperglycemia and insufficiency of secretion or 
action of endogenous insulin. Although the etiology of diabetes 
is not well defined, aging is a major factor in the development 
and progression of diabetes. Due to functional insufficiency, the 
vitamin B6 status of elderly individuals may be subject to higher 
variability than that of younger adults who are frequently taken 
as references. Moreover, it is reported that plasma PLP level 
is affected by age and gender [1].
It has been reported that vitamin B6 may be involved in the 
metabolism of carbohydrate. Pyridoxal 5'-phosphate (PLP), the 
active form of vitamin B6, acts as an integral part of glycogen 
phosphorylase (EC 2.4.1.1.) which catalyzes the breakdown of 
glycogen [2]. A deficiency of vitamin B6 is associated with 
impaired gluconeogenesis [3] and impaired glucose tolerance [4]. 
It has also been reported that vitamin B6 deficiency can lead 
to a decrease in the level of circulating insulin as well as pancreas 
function and relates to increased risk of coronary artery disease 
in animal models [5,6]. Thus, proper vitamin B6 status can be 
deemed an important factor in the care of type 2 diabetes for 
the prevention of degenerative complications. However, there 
have been few reports on vitamin B6 status in the Korean elderly 
population or in those with diabetes.
Therefore, the aim of the present study was to assess vitamin 
B6 status using plasma PLP levels and vitamin B6 intakes of 
Korean patients with newly diagnosed type 2 diabetes since 
plasma PLP level [7,8] and vitamin B6 intake have been the most 
accepted and widely used indices of vitamin B6 status in the 
last decade. In addition, these status indices were compared to 
those of age and gender-matched healthy non-diabetic subjects 
to exclude variance from age, as well as gender effects. 
Subjects and Methods
Subjects 
Sixty-four patients with newly diagnosed type 2 diabetes and 
8-11% glycated hemoglobin (A1C), which is used primarily to 
identify average plasma glucose concentrations over a prolonged 
period of time, and 28 age-matched healthy non-diabetic subjects 
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Category
Non-diabetic Diabetic
Men
(n = 15)
Women
(n = 13)
Total
(n = 28)
Men
(n = 36)
Women
(n = 28)
Total
(n = 64)
Age (yrs) 50.6 ± 12.3 49.5 ± 9.8 50.0 ± 10.8 47.9 ± 11.7 55.4 ± 13.6 51.5 ± 12.9
Height (cm) 167.1 ± 4.6 157.0 ± 7.0 161.0 ± 7.9 170.6 ± 5.9 156.3 ± 6.2 164.0 ± 9.5
Weight (kg) 66.1 ± 8.9 52.4 ± 8.5 59.2 ± 11.0 72.7 ± 10.0 63.7 ± 6.5 68.7 ± 10.3**
3)
BMI
2) 23.6 ± 2.6 21.2 ± 2.6 22.5 ± 3.1 24.9 ± 2.8 26.1 ± 2.2 25.5 ± 2.6**
1) Diabetic  subjects  had  newly  diagnosed  type  2  diabetes  with  8-11%  A1C  and  non  diabetic  subjects  were  age-matched. 
2) BMI;  Body  mass  index = weight(kg)/height(m
2)
3) ** Significant  difference  between  non-diabetic  and  diabetic  subjects  at  P < 0.01 
Table 1. General characteristics of non-diabetic and diabetic
1) subjects 
Nutrient Non-diabetic (n = 28) Diabetic (n = 64)
Energy (kcal) 1,917 ± 376 2,093 ± 311*
2)
Carbohydrate (g) 290 ± 43.7 323 ± 56.3
ns
Total protein (g) 83.9 ± 19.3 91.9 ± 26.7
ns
  Animal protein (g) 39.7 ± 18.7 47.8 ± 24.0
ns
  Plant protein (g) 44.1 ± 10.1 44.1 ± 11.7
ns
Total fat (g) 46.2 ± 16.4 52.0 ± 26.2
ns
  Animal fat (g) 23.9 ± 15.6 27.7 ± 16.9
ns
  Plant fat (g) 22.3 ± 9.79 24.3 ± 16.1
ns
Cholesterol (mg) 217 ± 131 267 ± 196
ns
Calcium (mg) 621 ± 227 684 ± 317
ns
Phosphorus (mg) 1,108 ± 214 1,205 ± 357
ns
Iron (mg) 17.0 ± 4.76 19.0 ± 5.91
ns
Sodium (mg) 5,478 ± 1674 5,159 ± 1,909
ns
Potassium (mg) 3,236 ± 717 3,339 ± 923
ns
Vitamin A (RE) 924 ± 627 83.6 ± 460
ns
Vitamin B1 (mg) 1.32 ± 0.41 1.39 ± 0.49
ns
Vitamin B2 (mg) 1.24 ± 0.33 1.24 ± 0.38
ns
Vitamin B6 (mg) 2.51 ± 0.91 2.53 ± 0.81
ns
Niacin (NE) 19.1 ± 6.65 19.0 ± 6.37
ns
Vitamin C (mg) 114 ± 55.3 141 ± 97.7
ns
1) Diabetic subjects had newly diagnosed type 2 diabetes with 8-11% A1C and non 
diabetic  subjects  were  age-matched. 
2) P-value,  ns:  not  significant  at  P < 0.05
Table 2. Daily nutrient intakes of non-diabetic and diabetic
1) subjects 
were recruited consecutively from the diabetes clinic at E 
Hospital between February and April, 2005. Subjects were 
excluded before recruitment if they were taking supplemental 
vitamins, including multivitamins. 
Dietary intake and anthropometric measurements
Dietary vitamin B6 intake and food sources were estimated with 
the 24 hour recall method. The subjects each reported three 
consecutive daily dietary intakes with the help of a trained 
interviewer. Food portion sizes were estimated by using standard 
household measures and published average portion sizes [9]. 
Nutrient intakes were estimated using a computer-aided nutritional 
analysis program developed by the Korean Nutrition Society [10]. 
When information was unavailable for a particular food, a value 
was assigned based on values for similar foods. The foods in 
the vitamin B6 database were categorized into those of animal 
or plant origin, and the amount of daily vitamin B6 provided 
by these two categories was calculated for each person. On the 
day of dietary data collection, weights and heights were measured 
and body mass index (BMI) was calculated from the measurements 
of body weight and height.
Biochemical and statistical analysis
After a 12-hour fast, venous blood was used for the assessment 
of vitamin B6  status and biochemical indices. Immediately 
following blood draw into heparinized vacutainers, the blood was 
centrifuged at 3,000 rpm for 15 min to separate the plasma. The 
plasma was stored at -20℃ in aliquots until analyzed. Plasma 
PLP concentration was measured using the HPLC method [11], 
which was modified as follows: Mobile phase (0.1 M potassium 
dihydrogen phosphate containing 0.1 M sodium perchlorate, 0.5 
g/L sodium bisulfite, pH 3) was pumped at a flow rate of 1.0 
ml/min into the column (Bondapack ODS column, 3.9×300 mm, 
10 μm porus packing, C18, Waters). The plasma was added to 
perchloric acid (0.8 M) and allowed to sit for one hour to release 
PLP from the protein. This mixture was then centrifuged (18,000 
rpm, 4℃, 15 min) and the supernatant removed. One hundred 
microliters of supernatant was loaded in the sample loop and 
then injected into the column. 
Statistical analyses were carried out using the Statistical 
Analysis System (SAS). Pearson's correlation coefficient was 
used to determine possible relationships among the indices of 
vitamin B6 status and blood biochemical indices. Values for 
vitamin B6 status were regressed based on vitamin B6 intake and 
dietary vitamin B6 to protein ratio. 
Results
Because aging is one of the major factors affecting both plasma 
PLP levels and the development and progression of diabetes, 
comparisons of plasma PLP concentrations of diabetic patients 
to those of age-matched healthy non-diabetic subjects are important. 
Sixty-four diabetic patients and 28 age-matched non-diabetic 
subjects participated in this study, with mean age being 50 years 
for the diabetic patients and 51.5 years for the non-diabetic 
subjects. The characteristics of the subjects are given in Table 
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Non-diabetic
(n = 28)
Diabetic
(n = 64)
Total vitamin B6 (mg/day) 2.51 ± 0.91 2.53 ± 0.81
ns2)
Vitamin B6/1,000 kcal (mg) 1.31 ± 0.42 1.20 ± 0.32
ns
Percent of Korean RDA (%)
1) 179.0 ± 65.4 180.0 ± 57.9
ns
Mean Plasma PLP (nmol/L) 80.0 ± 61.2 69.2 ± 38.5
ns
Subjects plasma PLP < 30 nmol/L (%) 8.3 9.7
1) Diabetic subjects had newly diagnosed type 2 diabetes with 8-11% A1C and non 
diabetic  subjects  were  age-matched. 
2) P-value,  ns:  not  significant  at  P < 0.05
Table 3. Dietary vitamin B6 intake and plasma PLP levels of non-diabetic and 
diabetic
1) subjects 
Plasma PLP (nmol/L)
3)
Non-diabetic (n = 28) Diabetic (n = 64)
Glucose (mg/dl) 0.033
ns2) 0.211
ns
Postprandial glucose (mg/dl) 0.160
ns 0.243
ns
Triglyceride (mg/dl) -0.125
ns -0.138
ns
Albumin (g/dl) -0.066
ns 0.075
ns
Total cholesterol (mg/dl) -0.112
ns 0.048
ns
1) Diabetic subjects had newly diagnosed type 2 diabetes with 8-11% A1C and non 
diabetic  subjects  were  age-matched. 
2) P-value,  ns:  not  significant  at  P < 0.05
3) Plasma  pyridoxal  5'-phosphate  levels  of  non-diabetic  and  diabetic  subjects
Table 4. Correlations between plasma PLP level and biochemical values of the
diabetic subjects
1) 
Vitamin B6 intake (mg/day) Dietary vitamin B6 to protein ratio (mg/g protein)
Fig. 1. Distribution of vitamin B6 intake in non-diabetic and diabetic
1) subjects. 
1) Diabetic subjects had newly diagnosed type 2 diabetes with 8-11% A1C and non diabetic
subjects  were  age-matched. 
and non-diabetic subjects. There was a significant difference in 
daily total calorie intake between the diabetic and non-diabetic 
groups (1,917 ± 376 vs 2,093 ± 311 kcal/d) due to excess weight 
in the diabetic subjects. However, there were no differences in 
intakes of other nutrients including vitamin B6. Table 3 shows 
dietary vitamin B6 intake and plasma PLP levels for the 
non-diabetic and diabetic subjects. There were no differences in 
intake of total vitamin B6 (2.51 ± 0.91 vs 2.53 ± 0.81 mg/d) or 
vitamin B6/1,000 kcal (1.31 ± 0.42 vs 1.20 ± 0.32 mg) between 
the diabetic and non-diabetic groups. The intakes of total vitamin 
B6 were above the Korean RDA for both groups. In the diabetic 
patients, the mean plasma PLP level was 15% lower as compared 
to the non-diabetic subjects (80.0 ± 61.2 vs 68.2 ± 38.5 nmol/L), 
but this difference was not statistically significant due to a large 
standard deviation. This indicates that the percentage of diabetic 
subjects whose plasma PLP concentration was < 30 nmol/L was 
higher than that of the non-diabetic group. Fig. 1 shows the 
frequency distribution of daily vitamin B6 intake, and its relative 
intake to daily protein intake ratio. Daily vitamin B6 intake was 
not normally distributed in either the non-diabetic or diabetic 
subjects, and the declination was steeper in the diabetic patients. 
Fig. 2 shows there was no significant correlation between plasma 
PLP level and intake of vitamin B6 in either the non-diabetic 
subjects or diabetic patients. Also, plasma PLP levels and intakes 
of vitamin B6 were more widely scattered in the diabetic patients 
compared to the non-diabetic subjects. Table 4 shows that no 
significant correlations were found between plasma PLP level 
and biochemical risk indices including plasma levels of fasting 
glucose, postprandial glucose, triglyceride, albumin, and total 
cholesterol in either the non-diabetic subjects or diabetic patients.
Discussion
Because there were no differences in total vitamin B6 intake 
and vitamin B6/1,000 kcal between the diabetic and non-diabetic 
groups, it is considered that the higher energy intake in diabetes 
patients did not affect intake of vitamin B6. A possible explanation 
for the tendency of lower vitamin B6 status is based on plasma 
PLP level, which has been suggested as the best single status 
indicator because it appears to reflect tissue stores. In the diabetic 
subjects, the mean plasma PLP level was 15% lower than that 
of the non-diabetic subjects (80.0 ± 61.2 nmol/L vs 68.2 ± 38.5 
nmol/L), but this difference was not statistically significant due 
to a large standard deviation. 
However, even though there were no differences in total 
vitamin B6 intake and vitamin B6/1,000 kcal between the diabetic 
and non-diabetic groups, and intakes of total vitamin B6 were 
above the Korean RDA in both groups, the percentage of subjects Hee Jung Ahn et al. 37
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Fig. 2. Scatter plots of plasma PLP levels and vitamin B6 intake in non-diabetic and diabetic
1) subjects. 
1) Diabetic subjects had newly diagnosed type 2 diabetes with 
8-11%  A1C  and  non  diabetic  subjects  were  age-matched. 
with a plasma PLP concentration < 30 nmol/L (the proposed 
cutoff as an index of adequacy in diabetic patients) was higher 
in the diabetic subjects as compared to non-diabetic subjects. 
Also, plasma PLP levels and intakes of vitamin B6 were more 
widely scattered in the non-diabetic group as compared to those 
of the diabetic group. Thus, if an eccentric value were considered, 
the 15% lower mean plasma PLP level in the diabetic subjects 
compared to that of the non-diabetic subjects is thought to be 
a meaningful decrease in a clinical situation, although this 
difference was not statistically significant. In addition, the results 
of this study are consistent with previous studies where circulating 
levels of plasma pyridoxal 5'-phosphate and total vitamin B6 
significantly decreased under conditions of hyperglycemia [12-14].
However, recent epidemiology of plasma PLP in the U.S. 
population showed there was no difference between diabetes and 
non-diabetes subjects, regardless of using supplemental vitamin 
B6 [15]. This discrepancy may be explained by differences in 
major vitamin B6 sources, because several studies have indicated 
that the utilization of vitamin B6 from animal derived foods is 
more efficient than that from plant foods [16,17]. Furthermore, 
it was reported that Koreans obtain approximately 65% of 
vitamin B6 from plant sources [18,19], whereas in the American 
diet, approximately 50% of dietary vitamin B6 is from meat and 
the other 50% is from plant-based foods [20]. 
There was a previous review on age-associated B vitamin 
deficiency as a determinant of chronic diseases [21], and 
estimations of how much vitamin B6 is required in diabetes must 
take into account all potential age-related alterations. By the 
comparison of vitamin B6 status in diabetic patients to that of 
age-matched healthy non-diabetic subjects in this study, the 
tendency for a lower plasma PLP level in diabetic patients might 
not be due to age-related alterations. 
This lowered level of plasma PLP in diabetic patients may 
be due to either lower intake of vitamin B6 or altered distribution 
of PLP in diabetic patients. B vitamin intake is dependent on 
the food supply and many studies have demonstrated that 
Non-diabetic Non-diabetic
Diabetic Diabetic
Dietary vitamin B6 intake (mg/day)
Dietary vitamin B6 intake (mg/day)
Dietary vitamin B6 to protein ratio (mg/g)
Dietary vitamin B6 to protein ratio (mg/g)38 Vitamin B6 status in Koreans with type 2 diabetes
increased protein intake causes a relative decrease in B6  status, 
as judged by a variety of B6  status indicators [22-24]. Furthermore, 
in this study, vitamin B6 intake was highly correlated to intakes 
of energy and protein. This has led some to define B6  require-
ments in terms of protein intake or energy intake. However, there 
was no difference in vitamin B6 intake when expressed as either 
a ratio of vitamin B6 intake to daily protein intake or as the 
amount of vitamin B6 intake to a 1,000 calorie intake in this 
study. These data show that plasma PLP levels tended to be lower 
in the diabetic subjects than in the non-diabetic subjects although 
there was no difference in vitamin B6 intake. Thus, in this study, 
the lower plasma PLP levels of the diabetic patients might not 
have been due to insufficient intake of vitamin B6, but instead 
might be due to altered distribution of PLP in diabetic patients. 
The mechanism involved in altered distribution of PLP in 
diabetes could be that elevated plasma glucose reduces plasma 
PLP levels and xanthurenic acid excretion due to abnormal 
tryptophan metabolism; xanthurenic acid forms xanthurenic 
acid-insulin complexes that reduce insulin sensitivity and result 
in elevated blood glucose levels [25]. Decreases of mitochondria 
pyridoxal phosphate and aspartate aminotransferase have been 
observed in diabetic animals [26]. It was also reported that urinary 
excretions of 3-hydroxykynurenine and 3-hydroxyanthranilic acid 
were increased in diabetic animals, and this might lead to the 
inhibition of islet insulin secretion [27]. 
In clinical situations, the question still remains whether altered 
distribution of PLP contributes to the development of degenerative 
complications, or results from those complications. Because no 
significant correlations were found between plasma PLP levels 
and any of the biochemical risk indices of degenerative diabetes 
complications, such as plasma levels of fasting glucose, postprandial 
glucose, triglyceride, albumin, and total cholesterol, in either the 
non-diabetic or diabetic subjects of this study, the cause-effect 
nature of this relationship could not be clarified. However, 
considering the major complications that occur in diabetic 
patients, maintaining normal vitamin B6 status is an important 
diet strategy for diabetic patients since retrospective studies have 
suggested the association between risk of cardiovascular disease 
and vitamin B6 status, although the cause-effect nature of this 
relationship has not been clarified [28-31]. Prospective studies 
also suggest that populations with higher PLP concentrations 
have lower risk of coronary heart disease [32,33]. 
Therefore, despite the many uncertainties regarding the mode 
of action, these results suggest that plasma PLP levels should 
be monitored in pre-diabetic patients with diabetic risk factors 
and in newly diagnosed diabetic patients for long-term management 
of diabetes, even though this factor is not a major risk factor 
that contributes to the development of degenerative complications 
in certain patients. The principal limitations of this study were 
the cross-sectional design and that a causative nature of the 
association could not be established. 
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